All insights
SafeCDx 7 min read August 9, 2026

SafeCDx: The Infrastructure Layer for Connected Diagnostics

Consumers, clinicians, manufacturers and public-health organizations increasingly need infrastructure around the test:

HealthCheck Editorial Team
SafeCDx

A diagnostic product does not end at the result

The physical diagnostic is only one component of the modern testing experience.

Consumers, clinicians, manufacturers and public-health organizations increasingly need infrastructure around the test:

  • How was the test identified?
  • Was it expired?
  • Was it performed correctly?
  • How was the result captured?
  • Can the result be trusted?
  • Can it enter the patient’s health record?
  • Does the patient need clinical care?
  • Can the information be reported or analyzed?

SafeCDx is designed to provide that infrastructure.

What is SafeCDx?

SafeCDx is HealthCheck’s connected-diagnostics platform for digitally orchestrating supported at-home, point-of-care and remote point-of-care tests.

The platform connects the physical diagnostic product with its digital identity, workflow, result and downstream action.

A typical architecture is compact:

Activate → Identify → Guide → Capture → Validate → Normalize → Route

The exact workflow depends on the test’s approved intended use, labeling and technical capabilities.

1. Diagnostic onboarding

Before a test is made available through SafeCDx, the diagnostic profile can include:

  • regulatory status
  • intended use
  • manufacturer
  • product identifier
  • specimen type
  • target analytes
  • approved labeling
  • IFU
  • result logic
  • performance information
  • lot and expiration requirements
  • terminology mapping
  • digital workflow configuration

This creates a structured digital representation of the physical diagnostic product.

2. Product activation

A QR code or Data Matrix code can connect the physical product to the appropriate digital workflow.

A UUID can be used to maintain a persistent digital identity for the test.

The platform can then evaluate:

  • product type
  • lot
  • expiration
  • prior activation
  • supported workflow
  • recall or invalid-product status

This turns packaging into a secure entry point to the connected-care experience.

3. Guided test workflow

SafeCDx can present digital guidance based on the approved product workflow.

That may include:

  • collection guidance
  • preparation
  • timers
  • sequence checks
  • instructional video
  • image examples
  • quality-control prompts

The digital experience should remain aligned with the product’s approved labeling and should not expand its intended use.

4. Result capture

The result may enter SafeCDx through several supported methods:

  • direct device transmission
  • NFC
  • Bluetooth
  • camera capture
  • digital reader
  • computer vision
  • patient attestation
  • clinician confirmation

Different products require different validation approaches.

5. Provenance and authentication

Connected diagnostics become substantially more useful when the result carries context about how it was generated.

SafeCDx can associate the result with information such as:

  • test identifier
  • product
  • lot
  • expiration
  • timestamp
  • workflow
  • device
  • image
  • user attestation
  • interpretation method
  • clinical review status

That provenance supports traceability and downstream confidence.

6. Standards-based result representation

The result should not remain trapped inside a proprietary diagnostic application.

SafeCDx can normalize diagnostic information into standards-based healthcare structures using technologies such as:

  • FHIR
  • LOINC
  • SNOMED CT
  • structured device metadata

That allows the result to become part of broader healthcare interoperability.

7. Clinical action

For supported programs, SafeCDx can connect the diagnostic workflow directly to clinical care.

For example:

Result + Symptoms + History → Eligibility → Clinician Review → Treatment / Follow-Up

This is where connected diagnostics become more than a digitized test.

They become an access point to healthcare.

SafeCDx and FDA connected-diagnostics work

FDA has identified connected diagnostics as an important response to the growth of OTC and POC testing outside traditional laboratory environments. Its Digital Diagnostics program specifically describes the need for improved diagnostic data capture, harmonization and transmission from non-lab settings.

FDA also identifies Safe Health Systems as the awardee leading its Open Connected Diagnostics initiative, focused on standards-based diagnostic data capture and interoperable developer tools.

SafeCDx extends that architectural approach into a reusable HealthCheck platform capability.

Designed for multiple diagnostic modalities

The architecture can support different connected modalities, including:

  • LFA imaging
  • NFC
  • Bluetooth
  • digital readers
  • molecular devices
  • remotely guided testing

That matters because the future diagnostic ecosystem will not be built around a single hardware format.

The platform layer must accommodate many.

The diagnostic becomes programmable

Connected diagnostic infrastructure transforms the test from an isolated physical product into a configurable healthcare endpoint.

The value is not simply digitizing the result.

It is connecting:

Product → Data → Patient → Clinician → Healthcare System

That is the role SafeCDx is designed to play.

Editorial note: This article is educational and does not provide medical, legal, coding, or reimbursement advice. Requirements change; verify the rules that apply to the specific service, patient, professional, payer, and jurisdiction.